シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 4,593,215株、対発行株数の割合は 5.98% です（2026-07-10公表時点、5機関が報告）。機関ごとの内訳を積み上げグラフで表示し、日次の合計残高（繰越反映）の推移もチャートで確認できます。
空売り残高（合計）の推移
- モルガン・スタンレーMUFG証券
- Barclays Capital Securities
- JPM Securities Japan Co
- GOLDMAN SACHS
- Nomura
- UBS
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/05/29 | 2,155,480 | 2.86% (+0.17%) |
| 2026/05/28 | 2,030,780 | 2.69% (0.00%) |
| 2026/05/27 | 2,025,180 | 2.69% (0.00%) |
| 2026/05/26 | 2,025,180 | 2.69% (0.00%) |
| 2026/05/25 | 2,025,180 | 2.69% (+0.08%) |
| 2026/05/22 | 1,968,280 | 2.61% (+0.04%) |
| 2026/05/21 | 1,936,780 | 2.57% (-0.10%) |
| 2026/05/20 | 2,011,780 | 2.67% (-0.10%) |
| 2026/05/19 | 2,088,580 | 2.77% (-0.18%) |
| 2026/05/18 | 2,228,980 | 2.95% (-0.12%) |
| 2026/05/15 | 2,317,880 | 3.07% (-0.53%) |
| 2026/05/14 | 2,721,780 | 3.60% (-0.04%) |
| 2026/05/13 | 2,747,980 | 3.64% (0.00%) |
| 2026/05/12 | 2,747,980 | 3.64% (+0.63%) |
| 2026/05/11 | 2,275,480 | 3.01% (0.00%) |
| 2026/05/08 | 2,275,480 | 3.01% (-0.62%) |
| 2026/05/07 | 2,743,380 | 3.63% (-0.15%) |
| 2026/05/01 | 2,832,880 | 3.78% (-0.10%) |
| 2026/04/30 | 2,897,880 | 3.88% (0.00%) |
| 2026/04/28 | 2,897,880 | 3.88% (-0.06%) |
| 2026/04/27 | 2,944,180 | 3.94% (-0.04%) |
| 2026/04/24 | 2,947,380 | 3.98% (-0.07%) |
| 2026/04/23 | 2,998,980 | 4.05% (+0.56%) |
| 2026/04/22 | 2,549,380 | 3.49% (+0.08%) |
| 2026/04/21 | 2,465,680 | 3.41% (+0.20%) |
| 2026/04/20 | 2,319,680 | 3.21% (-0.15%) |
| 2026/04/17 | 2,421,780 | 3.36% (-0.28%) |
| 2026/04/16 | 2,630,344 | 3.64% (-0.60%) |
| 2026/04/15 | 3,059,941 | 4.24% (-0.38%) |
| 2026/04/14 | 3,335,268 | 4.62% (-0.11%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全547件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| Barclays Capital Securities | 6/2 | 895,325 | 1.17% (-0.09%) |
| Barclays Capital Securities | 6/1 | 957,325 | 1.26% (+0.13%) |
| Barclays Capital Securities | 5/29 | 853,725 | 1.13% (+0.17%) |
| Barclays Capital Securities | 5/28 | 729,025 | 0.96% (-0.14%) |
| JPM Securities Japan Co | 5/28 | 486,551 | 0.64% (+0.14%) |
| Barclays Capital Securities | 5/25 | 831,525 | 1.10% (+0.08%) |
| Barclays Capital Securities | 5/22 | 774,625 | 1.02% (+0.04%) |
| Barclays Capital Securities | 5/21 | 743,125 | 0.98% (-0.11%) |
| JPM Securities Japan Co | 5/21 | 378,451 | 0.50% (+0.01%) |
| JPM Securities Japan Co | 5/20 | 373,251 | 0.49% (-0.10%) |
| Barclays Capital Securities | 5/19 | 823,325 | 1.09% (-0.18%) |
| Barclays Capital Securities | 5/18 | 963,725 | 1.27% (-0.12%) |
| Barclays Capital Securities | 5/15 | 1,052,625 | 1.39% (-0.07%) |
| UBS | 5/14 | 354,300 | 0.46% (-0.04%) |
| Barclays Capital Securities | 5/12 | 1,102,225 | 1.46% (+0.13%) |
| UBS | 5/12 | 380,500 | 0.50% (+0.01%) |
| Barclays Capital Securities | 5/8 | 1,010,225 | 1.33% (-0.13%) |
| Barclays Capital Securities | 5/7 | 1,107,025 | 1.46% (-0.11%) |
| UBS | 5/7 | 371,100 | 0.49% (-0.04%) |
| JPM Securities Japan Co | 5/1 | 450,051 | 0.59% (-0.10%) |
| Barclays Capital Securities | 4/28 | 1,172,325 | 1.57% (-0.06%) |
| Barclays Capital Securities | 4/27 | 1,218,625 | 1.63% (+0.06%) |
| JPM Securities Japan Co | 4/27 | 515,051 | 0.69% (-0.10%) |
| GOLDMAN SACHS | 4/24 | 815,204 | 1.09% (-0.07%) |
| Barclays Capital Securities | 4/23 | 1,168,325 | 1.57% (+0.14%) |
| GOLDMAN SACHS | 4/23 | 866,804 | 1.16% (-0.11%) |
| UBS | 4/23 | 395,300 | 0.53% (+0.05%) |
| Barclays Capital Securities | 4/22 | 1,066,025 | 1.43% (+0.08%) |
| Barclays Capital Securities | 4/21 | 982,325 | 1.35% (+0.20%) |
| Barclays Capital Securities | 4/20 | 836,325 | 1.15% (-0.15%) |